Drug Type siRNA |
Synonyms Cavisiran, ENB101-LNP, ENB 101 + [3] |
Target |
Action inhibitors |
Mechanism E7 inhibitors(HPV E7 inhibitors), HPV E6 inhibitors(HPV E6 inhibitors), RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Head and Neck Neoplasms | Preclinical | South Korea | 11 Apr 2024 | |
| Uterine Cervical Cancer | Preclinical | South Korea | 11 Apr 2024 |





